Diffuse Alveolar Hemorrhage: Blood, Sweat and Tears

Por Zejnullahu, Kreshnik, Khatami, Shabnam, Manesh, Reza Sedighi
Publicado no J Gen Intern Med (2016)

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins

Por Lockwood, William W., Zejnullahu, Kreshnik, Bradner, James E., Varmus, Harold
Publicado em 2012

Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma

Por Unni, Arun M, Lockwood, William W, Zejnullahu, Kreshnik, Lee-Lin, Shih-Queen, Varmus, Harold
Publicado no eLife (2015)

Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers

Por Yonesaka, Kimio, Zejnullahu, Kreshnik, Lindeman, Neal, Homes, Alison J., Jackman, David M., Zhao, Feng, Rogers, Andrew M., Johnson, Bruce E., Jänne, Pasi A.
Publicado em 2008

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

Por Ercan, Dalia, Zejnullahu, Kreshnik, Yonesaka, Kimio, Xiao, Yun, Capelletti, Marzia, Rogers, Andrew, Lifshits, Eugene, Brown, Alison, Lee, Charles, Christensen, James G., Kwiatkowski, David J., Engelman, Jeffrey A., Jänne, Pasi A.
Publicado em 2010

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

Por Engelman, Jeffrey A., Mukohara, Toru, Zejnullahu, Kreshnik, Lifshits, Eugene, Borrás, Ana M., Gale, Christopher-Michael, Naumov, George N., Yeap, Beow Y., Jarrell, Emily, Sun, Jason, Tracy, Sean, Zhao, Xiaojun, Heymach, John V., Johnson, Bruce E., Cantley, Lewis C., Jänne, Pasi A.
Publicado em 2006

Pre-existence and clonal selection of MET amplification in EGFR mutant NSCLC

Por Turke, Alexa B., Zejnullahu, Kreshnik, Wu, Yi-Long, Song, Youngchul, Dias-Santagata, Dora, Lifshits, Eugene, Toschi, Luca, Rogers, Andrew, Mok, Tony, Sequist, Lecia, Lindeman, Neal I., Murphy, Carly, Akhavanfard, Sara, Yeap, Beow Y., Xiao, Yun, Capelletti, Marzia, Iafrate, A. John, Lee, Charles, Christensen, James G., Engelman, Jeffrey A., Jänne, Pasi A.
Publicado em 2010

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

Por Koivunen, Jussi P., Mermel, Craig, Zejnullahu, Kreshnik, Murphy, Carly, Lifshits, Eugene, Holmes, Alison J., Choi, Hwan Geun, Kim, Jhingook, Chiang, Derek, Thomas, Roman, Lee, Jinseon, Richards, William G., Sugarbaker, David J., Ducko, Christopher, Lindeman, Neal, Marcoux, J. Paul, Engelman, Jeffrey A., Gray, Nathanael S., Lee, Charles, Meyerson, Matthew, Jänne, Pasi A.
Publicado em 2008

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

Por Yonesaka, Kimio, Zejnullahu, Kreshnik, Okamoto, Isamu, Satoh, Taroh, Cappuzzo, Federico, Souglakos, John, Ercan, Dalia, Rogers, Andrew, Roncalli, Massimo, Takeda, Masayuki, Fujisaka, Yasuhito, Philips, Juliet, Shimizu, Toshio, Maenishi, Osamu, Cho, Yonggon, Sun, Jason, Destro, Annarita, Taira, Koichi, Takeda, Koji, Okabe, Takafumi, Swanson, Jeffrey, Itoh, Hiroyuki, Takada, Minoru, Lifshits, Eugene, Okuno, Kiyotaka, Engelman, Jeffrey A., Shivdasani, Ramesh A., Nishio, Kazuto, Fukuoka, Masahiro, Varella-Garcia, Marileila, Nakagawa, Kazuhiko, Jänne, Pasi A.
Publicado em 2011